Treated mice exhibited preserved lung function and no Ph1 p 5-induced mast cell degranulation, suggesting the potential of CD19+ B cells as a prophylactic treatment for IgE-mediated allergies [53]. The gene discussed is IGHE; the disease is allergic disease.